All News #Library
Biotech
Partner Therapeutics announces submission of sBLA for BIZENGRI
15 Apr 2026 //
PR NEWSWIRE
Zenocutuzumab Extends Benefits in NRG1+ Pancreatic Cancer
09 Jan 2026 //
PR NEWSWIRE
Zenocutuzumab Shows Durable Efficacy in NRG1+ NSCLC
07 Dec 2025 //
PR NEWSWIRE
Zenocutuzumab-Zbco Receives FDA Breakthrough Designation
24 Oct 2025 //
PR NEWSWIRE
NEJM Publishes eNRGy Results for Zenocutuzumab in NRG1+ Cancer
05 Feb 2025 //
PR NEWSWIRE
BARDA, Partner Therapeutics Advance LEUKINE® for Sepsis Treatment
09 Jan 2025 //
PR NEWSWIRE
Partner`s Leukine® Receives Approval in Japan to Treat aPAP
03 Apr 2024 //
PR NEWSWIRE

Market Place
Sourcing Support